Department of Microbiology and Biotechnology Centre, Faculty of Science, M. S. University of Baroda, Vadodara 390002, India.
J Ethnopharmacol. 2012 Oct 31;144(1):201-7. doi: 10.1016/j.jep.2012.09.006. Epub 2012 Sep 11.
Medicinal plants traditionally used to treat malaria can provide quality leads towards identifying novel anti-malarial drugs. Here we combined this approach with target based drug discovery and explored Plasmodium specific lactate dehydrogenase (LDH) inhibitory activity of 8 Indian plants which are ethnically used to treat malaria.
LDH from Indian Plasmodium falciparum and Plasmodium vivax strains, were cloned and expressed in Escherichia coli, followed by purification of recombinant enzymes (rPfLDH and rPvLDH respectively). Extracts of 8 plants in different organic and aqueous solvents, were screened for their inhibitory activity on rPfLDH, rPvLDH and mammalian LDHs. Phyllanthus amarus aqueous extract was further tested for in vitro parasiticidal activity.
Aqueous extract of Phyllanthus amarus Schum. and Thonn. and chloroform extract of Murraya koenigii (L.) Spreng. exhibited profound and exclusive inhibitory effect on Plasmodium falciparum LDH (IC(50)=11.2 μg/ml ± 0.4) and Plasmodium vivax LDH (IC(50)=6.0 μg/ml ± 0.6) respectively. Moreover, Phyllanthus amarus aqueous extract also demonstrated antiplasmodial activity in vitro, on Chloroquine sensitive and resistant strains of Plasmodium falciparum (IC(50)=7.1 μg/ml ± 0.5 and 6.9 μg/ml ± 0.7 respectively).
Target specific screening of traditional herbs used in malaria treatment has proffered Phyllanthus amarus and Murraya koenigii extracts as hits which can optimistically provide novel antimalarial drugs.
传统上用于治疗疟疾的药用植物可以为寻找新型抗疟药物提供质量线索。在这里,我们将这种方法与基于靶标的药物发现相结合,探索了 8 种印度植物对疟疾的治疗作用,这些植物在民族医学上被用于治疗疟疾。
从印度间日疟原虫和恶性疟原虫株中克隆并在大肠杆菌中表达乳酸脱氢酶(LDH),然后分别纯化重组酶(rPfLDH 和 rPvLDH)。用不同的有机溶剂和水溶剂提取 8 种植物的提取物,筛选其对 rPfLDH、rPvLDH 和哺乳动物 LDH 的抑制活性。进一步测试了叶下珠的水提取物的体外杀寄生虫活性。
叶下珠的水提取物和芸香的氯仿提取物对恶性疟原虫 LDH(IC(50)=11.2μg/ml±0.4)和间日疟原虫 LDH(IC(50)=6.0μg/ml±0.6)表现出明显的、专一的抑制作用。此外,叶下珠水提取物对氯喹敏感和耐药的恶性疟原虫株也表现出体外抗疟活性(IC(50)分别为 7.1μg/ml±0.5 和 6.9μg/ml±0.7)。
对传统草药治疗疟疾的靶向特异性筛选提供了叶下珠和芸香提取物作为潜在药物,它们有望提供新型抗疟药物。